Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time?
- PMID: 28360536
- PMCID: PMC5365280
- DOI: 10.2147/BCTT.S127583
Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time?
Abstract
Whole breast external beam radiotherapy (WBEBRT) is commonly used as an essential arm in the treatment management of women with early-stage breast cancer. Dosimetry planning for conventional WBEBRT typically involves a pair of tangential fields. Advancement in radiation technology and techniques has the potential to improve treatment outcomes with clinically meaningful long-term benefits. However, this advancement must be balanced with safety and improved efficacy. Intensity-modulated radiation therapy (IMRT) is an advanced technique that shows promise in improving the planning process and radiation delivery. Early data on utilizing IMRT for WBEBRT demonstrate more homogenous dose distribution with reduction in organs at risk doses. This translates to toxicities reduction. The two common descriptors for IMRT are forward-planning "fields in field" and inverse planning. Unlike IMRT for other organs, the aim of IMRT for breast planning is to achieve dose homogeneity and not organ conformality. The aim of this paper was to evaluate whether IMRT is ready for prime time based on these three points: 1) workload impact, 2) the clinical impact on the patient's quality of life, and 3) the appropriateness and applicability to clinical practice.
Keywords: clinical practice; early-stage breast cancer; intensity-modulated radiation therapy; quality of life; radiotherapy; workload impact.
Conflict of interest statement
Disclosure The authors report no funding sources and no conflicts of interest in this work.
Figures
References
-
- WHO Fact Sheets by Cancer. [Accessed April 12, 2016]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
-
- American Cancer Society Radiation for Breast Cancer. 2016. [Accessed November 7, 2016]. Available from: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-tr....
-
- Darby S, McGale P, Correa C, et al. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–1716. - PMC - PubMed
-
- Kanapuru B, Ershler WB, Hesdorffer C, Jemal A, Yates JW. Long-term survival of older breast cancer patients: population-based estimates over three decades. Breast Cancer Res Treat. 2012;134(2):853–857. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
